openPR Logo
Press release

Prescription Hormonal Drugs in Gynecology Market to be Driven by High Prevalence of Hormonal Imbalance Rate in Women

08-05-2016 12:27 PM CET | Health & Medicine

Press release from: TMR-Research

Hormonal imbalance in women is caused due to abnormalities in the secretion of estrogen, progesterone and as well as androgens. A wide array of symptoms might be experienced by patients depending on the type of abnormality such as hot flushes, depression, vaginal dryness, excessive hair growth and abnormal vaginal bleeding. Environmental and genetic factors have an influence on women's fertility through their effect on hormonal function. Similarly, dysfunction of the HPO (hypothalamic-pituitary-ovarian) axis and/or other endocrine systems may cause infertility and other gynecological disorders. The correct clinical decision for treating these diseases can be made on pathogenetic basis.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12563

Disturbances related to the menstrual cycle lead to various syndromes such as polycystic ovary syndrome (PCOS), amenorrhea and premenstrual syndrome (PMS). Of all the above, PCOS is a common hormonal disorder seen among women that in the reproductive age. PCOS is a condition in which appearance of the ovaries in most, but not all women, is enlarged and features a number of tiny cysts located along the outer edge of each ovary. PCOS symptoms are observed in nearly 5% to 10% of women who are in their reproductive age (typically between 12 to 45 years).

PCOS is perceived to be among the leading causes of female sub-fertility. It is also among the most frequently reported endocrine problems in women in the reproductive age. Amenorrhea is a clinical condition wherein menstrual periods do not occur. Besides phases such as childhood, breastfeeding, pregnancy, and menopause, the absence of periods may point toward a problem in the female reproductive system. However, hormonal disruption is also a common cause for the absence of menstrual periods. Similarly, PMS is a medical condition that affects many women with childbearing age and causes variety of physical and psychological symptoms that occur just before menstrual cycle.

The prevalence of hormonal imbalance rate in women is high as the World Health Organization (WHO) estimates that PCOS affected 116 million women worldwide as of 2010 i.e. nearly 3.4% of the global female population. While in case of PMS, according to World Health Organization (WHO), in 2010, 199 million women had premenstrual syndrome i.e. nearly 5.8% of the global female population.

The major drivers of the hormonal drugs in gynecology market includes high awareness in female population regarding hormonal disorders, continuous research and development activities in the field of women healthcare and various government and organizational programs to educate women about the symptoms, precautions and treatments. The market for hormonal drugs in gynecology can be segmented on the basis of different drugs available in the market, different disease conditions and geography. Various drugs available for the treatment of hormonal disorders includes Depo-Provera, Prometrium, Provera, Alesse, Apri, Desogen, Junel Fe 1/20, Kariva, Loestrin Fe1/20, Vestura and others. Geographic segment of prescription hormonal drugs in gynecology market can be categorized into following regions: North America, Europe, Asia-Pacific and Rest of the World.

Brisdelle (low-dose paroxetine mesylate) product of Noven Pharmaceutical received approval in July 2013 against treatment of menopause condition. Brisdelle is a low-dose formulation of paroxetine mesylate, a selective serotonin reuptake inhibitor. Similarly, the new entity AZD4901 (Oral) is currently under phase II clinical trial for treatment of PCOS and this study is sponsored by Astra Zeneca. It is an interventional type of study including 56 as the target sample size.

The major players of prescription hormonal drugs in gynecology market includes Novartis AG, Pfizer, Inc., Berlex Laboratories, Inc., Ferring Pharmaceuticals, S.A., Duramed Pharmaceuticals, Inc. Xanodyne Pharmaceuticals, Inc., Bayer AG and others.

Browse Full Research Report: http://www.transparencymarketresearch.com/prescription-hormonal-drugs-gynecology-market.html

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prescription Hormonal Drugs in Gynecology Market to be Driven by High Prevalence of Hormonal Imbalance Rate in Women here

News-ID: 354361 • Views:

More Releases from TMR-Research

Micro-Electromechanical Systems (MEMS) Technology Market - Global Industry Size, Share, Trends, Analysis And Forecast 2015 - 2023
Micro-Electromechanical Systems (MEMS) Technology Market - Global Industry Size, …
The MEMS combines both electrical and mechanical components on single chip, thus enabling smart products with computational ability of microelectronics and perception, control capabilities of micro sensors and micro actuators. Strong growth for MEMS is expected in telecommunications and the medical end-use industries. With improvements in medical & pharmaceutical infrastructure, along with the increased healthcare spending in emerging nations, there will be a strong demand in countries like China and
Industrial Controls System Market to Grow at CAGR of 4.9% from 2015 to 2021
Industrial control systems are a network of interconnected equipment that are used for supervising and controlling physical equipment in several industrial environments. These systems include numerous control systems such as supervisory control and data acquisition (SCADA) systems, distributed control systems (DCS), and programmable logic controllers (PLC). They are primarily used for remote supervision, process automation, and critical infrastructure automation. SCADA systems are employed for obtaining data from remotely placed devices
Lighting Fixtures Market Witnessing Varying Impact From Increased Led Installations,Expected To Touch US$215.3 bn by 2021
Lighting Fixtures Market Witnessing Varying Impact From Increased Led Installati …
Lighting fixtures are electrical devices used to create artificial light using an electric lamp. Lighting fixtures have a fixture body and a light socket to hold a light bulb as well as to allow replacing it. A few types of fixtures may also have a switch to control the intensity of the light. An electric connection to the power source is necessary to power lighting fixtures. These fixtures can be
Global Autoimmune Disease Diagnostics Market to Benefit from Rising Health Care …
As autoimmune diseases grip millions around the world, the research and development of novel therapeutics and diagnostics is gaining momentum. With the incidence of autoimmune diseases rapidly increasing around the world, efficient autoimmune disease diagnostics is now considered indispensable. Avail Free Sample Research Report: http://bit.ly/1SVvP7t Compelled by these factors, governments around the world have considerably increased their healthcare spending. The research and development of novel diagnostics has also paced up in the

All 5 Releases


More Releases for PCOS

Polycystic Syndrome (PCOS) Market Expected to Reach USD 7.9 Billion by 2034
Polycystic Syndrome (PCOS) is a complex hormonal disorder affecting women of reproductive age, characterized by irregular menstrual cycles, excessive androgen levels, and polycystic ovaries. Beyond its reproductive implications, PCOS is closely linked to metabolic issues such as insulin resistance, obesity, and increased risk of type 2 diabetes and cardiovascular diseases. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70728 Over the past decade, growing awareness, improved diagnostic capabilities, and greater emphasis
Empowering Women's Health: A New Era Dawns in the PCOS Therapeutics Market
Polycystic Ovarian Syndrome (PCOS) affects an estimated 8-13% of women of reproductive age worldwide, presenting a multifaceted challenge that spans hormonal imbalance, metabolic disruption, and reproductive health. Today, the PCOS therapeutics market stands at the forefront of medical innovation, as pharmaceutical companies, biotech startups, and academic researchers converge to address the unmet needs of millions of women. This industry outlines the latest trends, breakthrough therapies, and market dynamics shaping this
Global Efforts to Address Polycystic Ovarian Syndrome (PCOS) Gain Momentum
The Polycystic Ovarian Syndrome (PCOS) Treatment Market is expected to grow from an estimated USD 3514.5 million in 2024 to USD 5546.3 million in 2033, at a CAGR of 5.20%. Global initiatives to raise awareness and address Polycystic Ovarian Syndrome (PCOS) are making significant strides in improving women's health. The World Health Organization (WHO) highlights PCOS as a critical health disorder due to its impact on reproductive health, metabolic well-being,
Laser Hair Removal for PCOS: A Chicago Guide
Polycystic Ory Syndrome (PCOS) is a hormonal disorder that affects around 10% of women of reproductive age worldwide. PCOS leads to a range of symptoms like irregular menstrual cycles, insulin resistance, and more. The most challenging symptoms for many women with PCOS are excessive hair growth on their face, chest, and back. It's a condition known as hirsutism. Thanks to developments in laser hair removal Chicago https://vplaserhairremoval.com/laser-hair-removal-chicago-prices/ offers, individuals with
Discover Optimal PCOS Fertility Health Today with Dr. Angela Potter
Learn the secrets to optimal PCOS fertility health and improve the chances of pregnancy PORTLAND, OR - Polycystic ovarian syndrome (PCOS) is a condition often attributed to infertility, affecting more than five million women [https://www.endocrine.org/patient-engagement/endocrine-library/pcos] in the United States alone. Unfortunately, many women with PCOS are immediately pointed in the direction of in vitro fertilization (IVF) - a notoriously expensive procedure that does not guarantee a successful embryo transfer or pregnancy.
06-20-2024 | Health & Medicine
Fact.MR
PCOS Treatment Market Projected to Reach $6.84 Billion by 2034
According to a recent analysis by Fact.MR, the global (PCOS) treatments market is expected to experience significant growth in the coming years. This expansion is driven by several key factors: a rising incidence of PCOS, advancements in treatment methodologies, and a growing focus on women's health and wellness. Get Free Sample Research Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10043 PCOS is one of the most prevalent endocrine disorders among women of reproductive age globally. It manifests through symptoms